Ceramide synthase is known to be enhanced in LPS-mediated septic shock in Cers2-deficient mice [49], and inhibition of ceramide synthesis prevented diabetes, steatosis, and cardiovascular disease in rodents [50]. This evidence concerns the gene TLCD3B and steatosis.